{4:45 minutes to read} In a recent case, Genzyme Corp. v. Dr. Reddy’s Labs., Ltd. (Fed. Cir. 2017), the Federal Circuit affirmed the validity of patent No. 7,897,590. This patent is directed to a process to stimulate the mobilization of a donor’s bone marrow by administering both a “granulocyte-colony stimulating factor” and Plerixafor, a drug […]